Lawsuit attacks patent giving company control over genetic test for cancer risk – Washington Post

Lawsuit attacks patent giving company control over genetic test for cancer risk
Washington Post
They say that Myriad's patents on the isolated BRCA sequences impede research and women's access to their own genetic information through testing. ...

and more »

via Google News

Geneticology.com does not provide specific medical advice nor does it suggest any medical practice whatsoever. The data provided on all pages are informational only and does not constitute professional advice nor does it create a doctor/patient relationship. You should not use the information on geneticology to diagnose a disease or treat a medical condition. Any and all medical concerns should be addressed with a licensed and qualified physician or professional.

Geneticology – Genetic Testing Resources

Lawsuit attacks patent giving company control over genetic test for cancer risk – Washington Post

Recent Articles

Categories

Pages